Human tissue engineered products - drugs or devices? Tackling the regulatory vacuum

被引：22

作者：

Faulkner, A ^{[1
]}

Geesink, I

Kent, J

FitzPatrick, D

机构：

[1] Cardiff Univ, Sch Social Sci, Cardiff CF10 3WT, S Glam, Wales

[2] Natl Univ Ireland Univ Coll Dublin, Dublin 4, Ireland

[3] Univ W England, Bristol BS16 1QY, Avon, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 326卷 / 7400期

关键词：

D O I：

10.1136/bmj.326.7400.1159

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1159 / 1160

页数：2

共 11 条

[1]

ABRAHAM J, 2002, REGULATING MED EUROP

[2] Whose body is it anyway? Disputes over body tissue in a biotechnology age [J].

Andrews, L ;

Nelkin, D .

LANCET, 1998, 351 (9095) :53-57

[3] Skin substitutes: a review [J].

Balasubramani, M ;

Kumar, TR ;

Babu, M .

BURNS, 2001, 27 (05) :534-544

[4]

*DEP HLTH, MERG HLTH REG AG STR

[5] Acute excisional wounds treated with a tissue-engineered skin (Apligraf) [J].

Eaglstein, WH ;

Alvarez, OM ;

Auletta, M ;

Leffel, D ;

Rogers, GS ;

Zitelli, JA ;

Norris, JEC ;

Thomas, I ;

Irondo, M ;

Fewkes, J ;

Hardin-Young, J ;

Duff, RG ;

Sabolinski, ML .

DERMATOLOGIC SURGERY, 1999, 25 (03) :195-201

[6]

*EC SOC RES COUNC, 2001, ESRC RES PROGR INN H

[7]

*EUR COMM, OP CONS NEED COMM LE

[8]

HARDING S, 2002, BMJ-BRIT MED J, V324, P160

[9] Regulating human implant technologies in Europe - understanding the new era in medical device regulation [J].

Kent, J ;

Faulkner, A .

HEALTH RISK & SOCIETY, 2002, 4 (02) :189-209

[10]

Vacanti JP, 1999, LANCET, V354, pSI32

← 1 2 →